Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase 2 trial of flavopiridol and cisplatin in platinum-resistant ovarian cancer Peethambaram, P. P., Burton, J. K., Oberg, A. L., Gomez-Dahl, L. C., Isham, C. R., Tibodeau, J. D., Chomjak, T. L., Colevas, A., Wright, J. J., Erlichman, C., Bible, K. C. AMER ASSOC CANCER RESEARCH. 2007: 3380S–3381S
View details for Web of Science ID 000251969000150